Grantees' Use of President's Emergency Plan for AIDS Relief Funds
Through the President's Emergency Plan for AIDS Relief (PEPFAR), the Centers for Disease Control and Prevention (CDC) has altered the course of the global acquired immunodeficiency syndrome (AIDS) epidemic, saving millions of lives, improving the lives of countless others, and preventing millions of infections around the world. CDC received more than $1.9 billion in FY 2019 PEPFAR funds (about 95 percent of all PEPFAR funds received by HHS) to accelerate progress toward achieving an AIDS‑free generation and to create a lasting infrastructure that allows partner countries to respond to a range of health challenges and threats. To date, OIG has conducted a series of PEPFAR audits at CDC offices in five countries on three continents (Africa, North America, and Asia). OIG's PEPFAR oversight has helped CDC and other HHS staff learn important grant and program integrity lessons that apply to ongoing and future responses to infectious diseases. In previous audits of CDC offices in the United States and foreign countries, OIG identified noncompliance with policies, inadequate monitoring of grantees, and internal control weaknesses in the awarding of PEPFAR funds. We will determine whether CDC has: (1) effectively awarded, monitored and accounted for PEPFAR funds in accordance with Federal regulations, HHS Departmental regulations, and the Office of the U.S. Global AIDS Coordinator and Global Health Diplomacy guidance; and (2) taken corrective action to implement internal controls, including adhering to policies and procedures for awarding and monitoring PEPFAR funds.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|Completed (partial)||Centers for Disease Control and Prevention||Grantees' Use of President's Emergency Plan for AIDS Relief Funds||Office of Audit Services||A-04-19-01015;